Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P01178 (oxytocin)
 15,767 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Tissue pieces from the wall (i.e. tunica albuginea with adjacent theca externa) of human follicles were incubated with and without various hormones and their potential influence upon the collagenolytic activity was evaluated. Following incubation the collagenase activity was determined in the incubation medium by measurement of the hydrolytic activity against the synthetic peptide 2,4-dinitrophenyl-Pro-Gln-Gly-Ile-Ala-Gly-Gln-D-Arg-OH. Stimulated collagenolytic activity was seen in the presence of relaxin and oxytocin whereas prostaglandin E2, prostaglandin F2 alpha, progesterone and 17 beta-estradiol were without effect. It is concluded that the stimulated collagenolytic activity induced by relaxin and oxytocin may be of importance for the degradation of collagen which occurs prior to follicular rupture.
 ...
PMID:Hormonal effects on collagenolytic activity in the isolated human ovarian follicular wall. 301 21

Data on the structure, quantitation, origins and functions of the large luteal (LL) and small luteal (SL) cells of sheep, goats and cattle are reviewed. Both LL and SL cells show ultrastructural features consistent with a steroidogenic function. However, in addition to differences in size and shape, LL cells differ from SL cells primarily in possessing large numbers of secretory granules, suggesting an additional protein/polypeptide synthetic and secretory function. In sheep, morphometric estimates show that the corpus luteum (CL) contains approximately equal to 10 X 10(6) LL cells and approximately equal to 50-60 X 10(6) SL cells: individual LL cells are approximately equal to X 6 greater in volume than SL cells. During formation of the CL, granulosa and theca cells are incorporated, and evidence suggests that granulosa cells give rise to LL cells and theca cells to SL cells. However, SL cells, or cells of thecal origin, may also give rise to some LL cells. Both LL and SL cells produce progesterone in vitro. On a per cell basis, LL cells produce more progesterone than do SL cells, but SL cells show a much greater progesterone-secretory response to LH. Oxytocin is synthesized, and secreted in granule form, only by the LL cells, and relaxin, whose presence has been demonstrated convincingly only in cattle, also appears to be produced only by LL cells. The two types of luteal cell in ruminants therefore show major differences in function: the occurrence of any significant functional interaction remains to be established.
 ...
PMID:Heterogeneous cell types in the corpus luteum of sheep, goats and cattle. 330 24

The variety of peptides synthesized by the corpus luteum (relaxin, vasopressin, oxytocin and oxytocin-related neurophysin) and their possible intracellular effects are reviewed. After luteinization of the granulosa cells and in response to LH and FSH, the output of oxytocin is increased. In addition, insulin-like growth factor is a very potent stimulus of oxytocin secretion. Although luteal cells respond to gonadotrophins by increased production of progesterone, there is no further secretion of oxytocin. Oxytocin is localized in large luteal cells which seem not to be under the direct control of gonadotrophins. Synthesis of luteal oxytocin seems to occur during the early luteal phase according to measurements of oxytocin mRNA. Highest tissue concentrations and secretion under in-vitro conditions were observed during the mid-luteal phase, and so synthesis, storage and secretion are unlikely to occur concomitantly. Under in-vitro conditions, oxytocin is secreted concomitantly with neurophysin and progesterone, and there appears to be some form of communication between small and large luteal cells for the secretion of progesterone and oxytocin under in-vivo conditions. Evidence has been obtained that oxytocin may have local effects in the ovary by inhibition of secretion (synthesis ?) of progesterone, especially during the early luteal phase. A mechanism can be suggested whereby, under physiological conditions, oxytocin may delay the increase of progesterone by inhibition of progesterone secretion and therefore delay down regulation of its own receptor. This would prolong the life-span of the CL and the oestrous cycle. Exogenous progesterone given on Days 1-4 shortens the cycle to about 12 days. The best evidence that oxytocin may be involved in controlling luteolysis comes from immunization experiments in ewes and goats, but there is no clear evidence of this type for cattle. Basal concentrations of oxytocin at the end of the luteal phase may interact with oxytocin receptors after the inhibitory effect of progesterone in the uterus is reduced, thus initiating synthesis of PGF-2 alpha.
 ...
PMID:Luteal peptides and intercellular communication. 330 25

The release of relaxin from cultured porcine luteal cells derived from pregnant sows was detected by a reverse hemolytic plaque assay. In this assay, luteal cells are cocultured in monolayers with protein-A-coupled ovine erythrocytes. In the presence of porcine relaxin antiserum and complement, a zone of hemolysis--a plaque--develops around relaxin-releasing luteal cells. Treatment with prostaglandin E2 (10(-8) and 10(-6) M) significantly accelerated the rate of plaque formation; in contrast, human chorionic gonadotropin (10-1,000 IU/ml) inhibited the rate of plaque formation. Oxytocin (10(-8) to 10(-4) M) had no detectable effect on relaxin release. However, none of these treatments or long-term preexposure to prostaglandin F2 alpha increased the total proportion of large luteal cells that released relaxin, which remained at about 50%. These results are consistent with the idea that prostaglandins of uterine and/or luteal origin and pituitary luteinizing hormone may contribute, alone or perhaps in combination, to the overall regulation of ovarian relaxin release during pregnancy in the sow. In addition, the results indicate that the effects of prostaglandins are restricted to a subpopulation of large luteal cells that release detectable amounts of relaxin in culture.
 ...
PMID:Detection of relaxin release by porcine luteal cells using a reverse hemolytic plaque assay: effect of prostaglandins E2 and F2 alpha, human chorionic gonadotropin, and oxytocin. 331 14

Adaptation of the uterus to the growing fetus necessitates remodelling of the uterine connective tissue. Proteoglycans, being a main constituent of the extracellular matrix, influence the physical properties of the tissue and play an important regulatory role for a number of functional events. The synthesis of glycosaminoglycans (GAGs), the carboxyhydrate side chains of proteoglycans, in tissue from the lower uterine segment of term pregnant women was investigated in vitro by measurement of 35SO4 and [14C]glucosamine incorporation. Prostaglandin E2 and oestradiol-17 beta significantly increased the synthesis of sulphated GAGs but decreased the incorporation of [14C]glucosamine, while relaxin, prostaglandin F2 alpha and oxytocin had no significant effect. To further explore the influence of prostaglandin E2, tissue specimens were incubated with [14C]glucosamine and GAGs separated into three fractions on cetylpyridinium chloride cellulose micro columns. Prostaglandin E2 was found to significantly reduce the synthesis of components recovered in the glycoprotein and hyaluronate fractions, whereas synthesis of components in the sulphated GAG fraction was increased. The results indicate that prostaglandin E2 and oestradiol-17 beta have differential effects on different GAGs whereas relaxin, oxytocin and prostaglandin F2 alpha have no effect.
 ...
PMID:Hormonal influence on glycosaminoglycan synthesis in uterine connective tissue of term pregnant women. 347 38

The effects of chronic infusion of porcine relaxin on oxytocin release were studied in lactating rats. Infusion of relaxin (4.2 micrograms/h for either 4 or 6 days) suppressed reflex milk ejection and reduced litter weight gain for 48 h compared with saline-infused controls. After 2 days, neither the rate of growth nor the frequency of milk ejection were significantly different from controls. For 24 h after the infusion of relaxin ended, litters gained weight more quickly than controls but there was no difference seen in the frequency of milk ejection. The effects on oxytocin release of stopping an infusion of relaxin after 3 days were investigated. There was a significant (P less than 0.01) rise in plasma oxytocin (up to 90 pmol/l) 30 min after the infusion was stopped, followed by a sustained rise in intramammary pressure. Treatment of relaxin-infused rats with naloxone (0.1 mg/kg) when the infusion was halted caused a more rapid release of oxytocin (within 2 min), a greater release of oxytocin (up to 140 pmol/l) and a prolonged rise in intramammary pressure.
 ...
PMID:Effects of chronic infusion of porcine relaxin on oxytocin release in lactating rats. 365 11

Experiments were carried out to investigate the effects of porcine relaxin on the course of gestation and delivery in the rat. Plasma relaxin was maintained at approximately 600 nmol/l from day 19 to day 23 of gestation by i.v. infusion from chronically implanted minipumps. Relaxin significantly (P less than 0.001) prolonged the length of gestation in 17 rats compared with controls, without causing dystocia or affecting the number of live births. Six rats gave birth during relaxin infusion. In these animals there was a significant (P less than 0.001) increase in the interval between successive deliveries compared with control animals, resulting in prolonged labour. The remaining 11 rats gave birth after the infusion was completed, when the interval between successive deliveries was significantly (P less than 0.025) shorter than controls. The results are consistent with the hypothesis that relaxin has a central action suppressing the release of oxytocin as well as a peripheral action on the myometrium and cervix.
 ...
PMID:Effects of porcine relaxin on the length of gestation and duration of parturition in the rat. 370 Dec 47

Equine relaxin (eRlx) immunoactivity has previously been measured in the mare during pregnancy using the porcine relaxin (pRlx) RIA (pRlx-RIA). This was not the optimal system for measurement of eRlx because the dose-response curve obtained with equine plasma was not parallel to the pRlx standard curve. A homologous eRlx-RIA has been developed and used to measure relaxin immunoactivity during pregnancy and parturition in the mare. Highly purified eRlx was used for the generation of antiserum in rabbits, preparation of tracer, and as assay standards. A double antibody eRlx RIA (eRlx-RIA) was developed which was highly specific and sensitive (0.023 ng relaxin/tube). The dose-response curve obtained with eRlx plasma was parallel to the equine standard curve while there was no parallelism noted between the pRlx and eRlx standard curves. This assay was utilized to measure eRlx in samples collected during pregnancy which were previously measured for relaxin content in the pRlx-RIA. It was found that the two assay systems gave almost identical patterns of secretion throughout pregnancy. The two assays differed in the amount of relaxin measured, with the eRlx-RIA measuring considerably higher amounts during gestation than the pRlx assay. In oxytocin-induced foalings, the differences became greater with the equine assay measuring as much as 10-fold greater concentrations.
 ...
PMID:Development of a homologous equine relaxin radioimmunoassay. 373 58

The effect of relaxin on electrically evoked release of oxytocin from the posterior pituitary was examined by monitoring changes in intramammary pressure in the anaesthetized lactating rat. The amount of oxytocin released by electrical stimulation of the neurohypophysis in vivo was dramatically reduced following i.v. injection of highly purified porcine relaxin (2.5-10 micrograms/rat). Relaxin inhibited oxytocin release in a dose-dependent manner and the onset of inhibition occurred within 6-10 min and lasted for 10-60 min. No effect on the sensitivity of the mammary gland to exogenous oxytocin was observed after relaxin treatment. During the period of inhibition, i.v. injection of the opioid antagonist naloxone chloride (1 mg/kg) completely and immediately restored electrically evoked oxytocin release. The neurohypophysis is known to contain endogenous opioid peptides, therefore the effect of relaxin on electrically stimulated release of oxytocin from the rat isolated neural lobe in vitro was examined. Relaxin (500-2000 ng/ml) failed to inhibit oxytocin release in vitro. The results suggest that relaxin can inhibit the release of oxytocin from terminals in the neurohypophysis, but by an indirect mechanism. This action appears to be mediated through endogenous opioid peptides whose source is not clear. They are unlikely to be of neurohypophysial origin and may probably come from the adrenal medulla, since acute adrenalectomy negated the inhibitory effect of relaxin on oxytocin release.
 ...
PMID:Effects of porcine relaxin on oxytocin release from the neurohypophysis in the anaesthetized lactating rat. 375 59

Experiments were carried out to establish whether infusion of relaxin prolongs gestation and labour in the rat by suppressing release of oxytocin, and whether the effects of relaxin on birth could be reversed by the opioid antagonist naloxone. Female rats were implanted with subcutaneous osmotic minipumps for the infusion of purified porcine relaxin into the jugular vein for 84 h from either day 19 or day 20 of gestation. Infusion of relaxin delayed the onset of labour and in those animals which delivered during relaxin infusion, delivery was longer by approximately 45 min. Plasma oxytocin levels 40 min after delivery of the first fetus were 45.25 +/- 3.6 pmol/l (mean +/- S.D.) in unoperated controls and significantly (P less than 0.01) depressed (23.89 +/- 3.9) in rats that delivered during infusion of relaxin. Rats that delivered after the infusion of relaxin had finished, gave birth significantly (P less than 0.05) faster than controls and plasma oxytocin levels were significantly (P less than 0.01) raised (77.87 +/- 15.9 pmol/l). Naloxone treatment (1 mg/kg; i.m.) given immediately after the delivery of the first fetus reversed the inhibitory effect of relaxin and the interval between successive deliveries was slightly faster than that of controls. Plasma oxytocin levels in relaxin-infused naloxone-treated rats were significantly (P less than 0.01) higher than values in unoperated control rats. The results confirm that relaxin suppresses oxytocin release possibly through an opioid system and this may be important in the control of the timing of birth.
 ...
PMID:Relaxin acts centrally to inhibit oxytocin release during parturition: an effect that is reversed by naloxone. 378 86


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>